Preclinical efficacy of targeting sphingolipid-metabolising enzymes for Friedreich’s ataxia treatment
Funder: Association Française de l'Ataxie de Friedreich (AFAF)Duration: February 2025 -
People
| Name | Telephone | Office | ||
|---|---|---|---|---|
|
Dr Sara Anjomani Virmouni Senior Lecturer in Biomedical Sciences
T: +44 (0)1895 268165
E: sara.anjomanivirmouni@brunel.ac.uk |
+44 (0)1895 268165 | sara.anjomanivirmouni@brunel.ac.uk |